Tissue archives to track blood borne pathogens in people receiving blood products

Transfusion and Apheresis Science

Volumn 29, Issue 3, 2003, Pages 269-274

  Ritchie, Bruce C ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; GENOMIC DNA;

BLOOD CLOTTING; BLOOD DISEASE; BLOOD SAMPLING; CANADA; CONFERENCE PAPER; DISEASE COURSE; DNA DETERMINATION; EXPOSURE; GENETIC ANALYSIS; HEALTH CARE PERSONNEL; HUMAN; INFORMATION PROCESSING; INFORMED CONSENT; LABORATORY TEST; PATHOGENESIS; PATIENT INFORMATION; SCREENING; STANDARDIZATION; VALIDATION PROCESS;

EID: 0142138723     PISSN: 14730502     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transci.2003.08.010     Document Type: Conference Paper

References (22)

1. Indech B. The international harmonization of human tissue regulation: regulatory control over human tissue use and tissue banking in select countries and the current state of international harmonization efforts. Food Drug Law J. 55(3):2000;343-372.
2. Winn D.M., Reichman M.E., Gunter E. Epidemiologic issues in the design and use of biologic specimen banks. Epidemiol. Rev. 12:1990;56-70.
3. Skene L. Who owns your body? Legal issues on the ownership of bodily material. Trends Mol. Med. 8(1):2002;48-49.
4. Skene L. Ownership of human tissue and the law. Nat. Rev. Genet. 3(2):2002;145-148.
5. Dalton R. Tribe blasts 'exploitation' of blood samples. Nature. 420(6912):2002;111.
6. Marshall E. Policy on DNA research troubles tissue bankers. Science. 271(5248):1996;440.
7. Basu S., Martin S.W., Phillips R.M., Puri R. Obtaining archived pathological material for biomedical research. Lancet. 361(9366):2003;1394.
8. Salter B., Jones M. Human genetic technologies, European governance and the politics of bioethics. Nat. Rev. Genet. 3(10):2002;808-814.
9. Fox M., McHale J. Regulating human body parts and products. Health Care Anal. 8(2):2000;83-86.
10. Helminski F. Formalities, good faith, and tissue donation. Mayo Clin. Proc. 69(10):1994;985-986.
11. Poon M.C., Landay A., Prasthofer E.F., Stagno S. Acquired immunodeficiency syndrome with Pneumocystis carinii pneumonia and Mycobacterium avium-intracellulare infection in a previously healthy patient with classic hemophilia. Clinical, immunologic, and virologic findings. Ann. Intern. Med. 98(3):1983;287-290.
12. Chen B.P., Rumi M.G., Colombo M.et al. TT virus is present in a high frequency of Italian hemophilic patients transfused with plasma-derived clotting factor concentrates. Blood. 94(12):1999;4333-4336.
13. Nichols W.C., Amano K., Cacheris P.M.et al. Moderation of hemophilia A phenotype by the factor V R506Q mutation. Blood. 88(4):1996;1183-1187.
14. van 't Veer C., Golden N.J., Kalafatis M., Simioni P., Bertina R.M., Mann K.G. An in vitro analysis of the combination of hemophilia A and factor V (LEIDEN). Blood. 90(8):1997;3067-3072.
15. Lee D.H., Walker I.R., Teitel J.et al. Effect of the factor V Leiden mutation on the clinical expression of severe hemophilia A. Thromb. Haemost. 83(3):2000;387-391.
16. Riddick A.C., Barker C., Sheriffs I.et al. Banking of fresh-frozen prostate tissue: methods, validation and use. BJU Int. 91(4):2003;315-323. discussion 323-4.
17. Stegmayr B., Asplund K. Informed consent for genetic research on blood stored for more than a decade: a population based study. BMJ. 325(7365):2002;634-635.
18. Brahams D. Brain banks. Lancet. 335(8684):1990;282-283.
19. McHale J. Waste, ownership and bodily products. Health Care Anal. 8(2):2000;123-135.
20. van Diest P.J. No consent should be needed for using leftover body material for scientific purposes (For). BMJ. 325(7365):2002;648-651.
21. O'Brien C. U.K. panel weighs tissue ownership. Science. 268(5210):1995;492.
22. Strauss E. The tissue issue: losing oneself to science? Sci. News. 152(12):1997;190-191.